SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-036128
Filing Date
2023-02-13
Accepted
2023-02-13 17:27:25
Documents
46
Period of Report
2023-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d271395d8k.htm   iXBRL 8-K 48807
2 EX-10.1 d271395dex101.htm EX-10.1 417515
3 EX-10.2 d271395dex102.htm EX-10.2 153416
4 EX-10.3 d271395dex103.htm EX-10.3 83751
5 EX-99.1 d271395dex991.htm EX-99.1 19703
6 EX-99.2 d271395dex992.htm EX-99.2 36793
7 EX-99.3 d271395dex993.htm EX-99.3 22071
11 GRAPHIC g271395ex99_2s10g1.jpg GRAPHIC 210920
12 GRAPHIC g271395ex99_2s11g1.jpg GRAPHIC 162118
13 GRAPHIC g271395ex99_2s12g1.jpg GRAPHIC 252981
14 GRAPHIC g271395ex99_2s13g1.jpg GRAPHIC 328607
15 GRAPHIC g271395ex99_2s14g1.jpg GRAPHIC 406082
16 GRAPHIC g271395ex99_2s15g1.jpg GRAPHIC 393479
17 GRAPHIC g271395ex99_2s16g1.jpg GRAPHIC 466738
18 GRAPHIC g271395ex99_2s17g1.jpg GRAPHIC 222996
19 GRAPHIC g271395ex99_2s18g1.jpg GRAPHIC 418181
20 GRAPHIC g271395ex99_2s19g1.jpg GRAPHIC 393477
21 GRAPHIC g271395ex99_2s1g1.jpg GRAPHIC 169054
22 GRAPHIC g271395ex99_2s20g1.jpg GRAPHIC 433091
23 GRAPHIC g271395ex99_2s21g1.jpg GRAPHIC 298358
24 GRAPHIC g271395ex99_2s22g1.jpg GRAPHIC 377692
25 GRAPHIC g271395ex99_2s23g1.jpg GRAPHIC 454438
26 GRAPHIC g271395ex99_2s24g1.jpg GRAPHIC 440666
27 GRAPHIC g271395ex99_2s25g1.jpg GRAPHIC 391369
28 GRAPHIC g271395ex99_2s26g1.jpg GRAPHIC 307896
29 GRAPHIC g271395ex99_2s27g1.jpg GRAPHIC 376748
30 GRAPHIC g271395ex99_2s2g1.jpg GRAPHIC 723945
31 GRAPHIC g271395ex99_2s3g1.jpg GRAPHIC 397749
32 GRAPHIC g271395ex99_2s4g1.jpg GRAPHIC 270839
33 GRAPHIC g271395ex99_2s5g1.jpg GRAPHIC 334450
34 GRAPHIC g271395ex99_2s6g1.jpg GRAPHIC 328832
35 GRAPHIC g271395ex99_2s7g1.jpg GRAPHIC 365031
36 GRAPHIC g271395ex99_2s8g1.jpg GRAPHIC 133945
37 GRAPHIC g271395ex99_2s9g1.jpg GRAPHIC 260681
38 GRAPHIC g271395g0213144509627.jpg GRAPHIC 3765
  Complete submission text file 0001193125-23-036128.txt   13951171

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA fusn-20230210.xsd EX-101.SCH 2511
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20230210_lab.xml EX-101.LAB 18681
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20230210_pre.xml EX-101.PRE 11669
40 EXTRACTED XBRL INSTANCE DOCUMENT d271395d8k_htm.xml XML 3630
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 23620154
SIC: 2836 Biological Products, (No Diagnostic Substances)